Patent details

EP3318272 Title: CGRP ANTIBODIES

Basic Information

Publication number:
EP3318272
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP172016032
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CGRP ANTIBODIES
French Title of Invention:
ANTICORPS ANTL-CGRP
German Title of Invention:
CGRP-ANTIKÖRPER
SPC Number:

Dates

Filing date:
07/06/2011
Grant date:
10/08/2022
EP Publication Date:
09/05/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/08/2022
EP B1 Publication Date:
10/08/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/06/2023
Expiration date:
07/06/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/08/2022
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:
CHAMBERS, Mark Geoffrey
Address:
United States (US)

2

Name:
ALLAN, Barrett
Address:
United States (US)

3

Name:
BENSCHOP, Robert Jan
Address:
United States (US)

4

Name:
DARLING, Ryan James
Address:
United States (US)

Priority

Priority Number:
353323 P
Priority Date:
10/06/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 16/26; A61K 39/00; C07K 16/18;

Publication

European Patent Bulletin

Issue number:
202232
Publication date:
10/08/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages